Triple-H Therapy for Cerebral Vasospasm Following Spontaneous Subarachnoid Hemorrhage / 国际脑血管病杂志
Article
em Zh
| WPRIM
| ID: wpr-560538
Biblioteca responsável:
WPRO
ABSTRACT
Cerebral vasospasm is the leading cause of disability and death in patients with spontaneous subarachnoid hemorrhage,and there is no definitive and effective treatment for it yet.Triple-H therapy is now the first choice in the treatment of cerebral vasospasm,but there are still more controversies about it. In recent years,there have been a number of studies about Triple-H therapy. This article reviews the implementation of Triple-H therapy,fluid selection,and prophylactic application.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
International Journal of Cerebrovascular Diseases
Ano de publicação:
2006
Tipo de documento:
Article